Evaluating Artificial Intelligence-Based Clinical Decision Support for Sepsis and ARDS

NCT ID: NCT07025096

Last Updated: 2025-12-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Clinical Phase

NA

Total Enrollment

350 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-12-05

Study Completion Date

2026-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Sepsis and acute respiratory distress syndrome (ARDS) are common in intensive care units. Managing sepsis and ARDS is inherently complex and requires making numerous decisions under uncertainty. Artificial intelligence (AI) clinical decision support systems (CDSSs) offer a promising approach to support care management for sepsis and ARDS.

The goal of this randomized, survey-based study is to compare treatment recommendations enacted by clinicians to those generated by an AI CDSS. The study will investigate whether an AI CDSS can generate treatment recommendations that are safe, appropriate, and indistinguishable to those provided by real clinicians.

In this study, participants (i.e., critical care clinicians) will review a series of critical care cases (vignettes) in an electronic survey. Each vignette will contain a de-identified case of a patient with sepsis and ARDS as well as treatment recommendations for the case. Participants will assess the safety and appropriateness of each treatment recommendations and answer whether they think the treatment recommendations came from the clinician or an AI CDSS.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sepsis Acute Respiratory Distress Syndrome (ARDS)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Participants will review a series of clinical vignettes. Each vignette will be randomized to show a treatment recommendation either from an artificial intelligence-based clinical decision support system (AI CDSS) or from the clinician in the case, reflecting actual clinical practice. Vignettes will be randomized equally, and participants will see an equal number of vignettes from each arm.
Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Artificial Intelligence

Critical care cases / vignettes in this arm will contain treatment recommendations generated by an artificial intelligence-based clinical decision support system. Each participant will review four vignettes from this arm.

Group Type EXPERIMENTAL

Artifical Intelligence-Generated Treatment Recommendations

Intervention Type OTHER

The clinical vignette will contain treatment recommendations which were generated by an artificial intelligence-based clinical decision support system.

Human Clinician

Critical care cases / vignettes in this arm will contain treatment recommendations that were enacted by the clinician in the actual case. Each participant will review four vignettes from this arm.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Artifical Intelligence-Generated Treatment Recommendations

The clinical vignette will contain treatment recommendations which were generated by an artificial intelligence-based clinical decision support system.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Working as a physician (i.e., MD, DO) or an advanced practice provider (i.e., nurse practitioner, physician assistant)
* Working at a hospital or medical center in medical critical care, anesthesia critical care, surgical critical care, or emergency medicine

Exclusion Criteria

* Has not completed a residency training program (i.e., medical intern or resident)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute of General Medical Sciences (NIGMS)

NIH

Sponsor Role collaborator

University of Pennsylvania

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gary Weissman, MD, MSHP

Role: PRINCIPAL_INVESTIGATOR

University of Pennsylvania

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Pennsylvania

Philadelphia, Pennsylvania, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R35GM155262

Identifier Type: NIH

Identifier Source: secondary_id

View Link

858201

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The APS Phenotyping Study
NCT06521502 RECRUITING